Drug Res (Stuttg) 2016; 66(03): 121-125
DOI: 10.1055/s-0035-1550042
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Cytotoxic Potential and Molecular Characterization of Fungal Endophytes from Selected High Value Medicinal Plants of the Kashmir Valley – India

R. A. Dar
1   Biotechnology Division, CSIR – Indian Institute of Integrative Medicine, Sanatnagar – Srinagar, Kashmir, India
,
P. H. Qazi
1   Biotechnology Division, CSIR – Indian Institute of Integrative Medicine, Sanatnagar – Srinagar, Kashmir, India
,
I. Saba
1   Biotechnology Division, CSIR – Indian Institute of Integrative Medicine, Sanatnagar – Srinagar, Kashmir, India
,
S. A. Rather
1   Biotechnology Division, CSIR – Indian Institute of Integrative Medicine, Sanatnagar – Srinagar, Kashmir, India
,
Z. A. Wani
2   Cancer Pharmacology Division, CSIR – Indian Institute of Integrative Medicine, Jammu – Tawi, India
,
A. K. Qazi
2   Cancer Pharmacology Division, CSIR – Indian Institute of Integrative Medicine, Jammu – Tawi, India
,
A. A. Shiekh
1   Biotechnology Division, CSIR – Indian Institute of Integrative Medicine, Sanatnagar – Srinagar, Kashmir, India
,
A. Manzoor
1   Biotechnology Division, CSIR – Indian Institute of Integrative Medicine, Sanatnagar – Srinagar, Kashmir, India
,
A. Hamid
2   Cancer Pharmacology Division, CSIR – Indian Institute of Integrative Medicine, Jammu – Tawi, India
,
D. M. Modae
2   Cancer Pharmacology Division, CSIR – Indian Institute of Integrative Medicine, Jammu – Tawi, India
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 28. Dezember 2014

accepted 05. Mai 2015

Publikationsdatum:
26. Mai 2015 (online)

Preview

Abstract

The present study explores the fungal endophytes from selected high value medicinal plants to check their activities at in-vitro and in-vivo level. The in-vitro cytotoxicity of selected endophytes revealed potent growth inhibition against human cancer cell lines of leukemia (THP-1), lung (A549), prostate (PC-3), colon (Caco-2), neuroblastoma (IMR-32) and breast (MCF-7) at a concentration of 100 µg/ml. Among them the endophytic strains i. e., IIIM2, IIIM3, IIIM7 and IIIM8 showed most significant growth inhibition against colon (Caco-2), prostate (PC-3), lung (A549) and leukemia (THP-1) cancer cell lines. At the in-vivo level maximum (58.95%) tumor growth inhibition was documented with the extract of IIIM2 against Ehrlich Ascites Carcinoma mouse modal. All the potent fungal endophytic strains were characterized using ITS 4 and ITS 5 region sequencing and phylogenetic analysis was ascertained among them. This paper confirms the 2 elite endophytic fungal strains, IIIM2 and IIIM8, have the potential to act as a source of new anticancer compounds.